Literature DB >> 22820315

Why do drugs for acute heart failure fail?

Adriaan A Voors, Dirk J van Veldhuisen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22820315     DOI： 10.1093/eurjhf/hfs122

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN： 1388-9842            Impact factor:   15.534


× No keyword cloud information.
  7 in total

Review 1.  Novel pharmacologic therapies in development for acute decompensated heart failure.

Authors:  Justin A Ezekowitz
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

Review 2.  Structures of soluble guanylate cyclase: implications for regulatory mechanisms and drug development.

Authors:  Opher Gileadi
Journal:  Biochem Soc Trans       Date:  2014-02       Impact factor: 5.407

3.  Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure.

Authors:  Emilene Breedt; Lydia Lacerda; M Faadiel Essop
Journal:  PLoS One       Date:  2017-06-20       Impact factor: 3.240

4.  A novel soluble guanylate cyclase activator with reduced risk of hypotension by short-acting vasodilation.

Authors:  Toshihiro Sawabe; Toshiki Chiba; Akihiro Kobayashi; Kosuke Nagasaka; Kazuyuki Aihara; Akiyuki Takaya
Journal:  Pharmacol Res Perspect       Date:  2019-03-04

5.  Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients.

Authors:  Yi Yu; Chunna Jin; Chengchen Zhao; Shiyu Zhu; Simin Meng; Hong Ma; Jian'an Wang; Meixiang Xiang
Journal:  Front Cardiovasc Med       Date:  2021-12-22

6.  Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.

Authors:  Christoph Maack; Michael Lehrke; Johannes Backs; Frank R Heinzel; Jean-Sebastien Hulot; Nikolaus Marx; Walter J Paulus; Patrick Rossignol; Heinrich Taegtmeyer; Johann Bauersachs; Antoni Bayes-Genis; Dirk Brutsaert; Heiko Bugger; Kieran Clarke; Francesco Cosentino; Gilles De Keulenaer; Alessandra Dei Cas; Arantxa González; Martin Huelsmann; Guido Iaccarino; Ida Gjervold Lunde; Alexander R Lyon; Piero Pollesello; Graham Rena; Niels P Riksen; Giuseppe Rosano; Bart Staels; Linda W van Laake; Christoph Wanner; Dimitrios Farmakis; Gerasimos Filippatos; Frank Ruschitzka; Petar Seferovic; Rudolf A de Boer; Stephane Heymans
Journal:  Eur Heart J       Date:  2018-12-21       Impact factor: 29.983

7.  Luhong Granules Prevent Ventricular Remodelling after Myocardial Infarction by Reducing the Metabolites TMAO and LPS of the Intestinal Flora.

Authors:  Tianshu Yang; Huiyan Qu; Xiaolong Song; Qian Liu; Xiaoli Yang; Jijie Xu; Tao Yang; Zhenzhen Lan; Wanjing Sha; Hua Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-16       Impact factor: 2.629
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.